{"title": "2019 Novel Coronavirus can be detected in urine, blood, anal swabs and oropharyngeal swabs samples", "doi": "10.1101/2020.02.21.20026179", "citation_id": "2020.02.21.20026179v1", "date": "2020-02-25", "laguage": "en", "journal_title": "medRxiv", "first_page": "2020.02.21.20026179", "abstract": "<p>We tested samples collected from nine patients diagnosed with coronavirus disease 2019 (COVID-19). The virus was found in urine, blood, anal swabs and oropharyngeal swabs. It is the first time for SARS-CoV-2 found in urine, though no urinary irritation was found.</p>", "twitter_description": "We tested samples collected from nine patients diagnosed with coronavirus disease 2019 (COVID-19). The virus was found in urine, blood, anal swabs and oropharyngeal swabs. It is the first time for SARS-CoV-2 found in urine, though no urinary irritation was found.\n\n### Competing Interest Statement\n\nThe authors have declared no competing interest.\n\n### Funding Statement\n\nThis study was supported by grants from the Natural Science Foundation of China (NSFC) (No. 81570539 and 81873572), Tackling of key scientific and emergency special program of Sun Yat-sen University (SYSU-TKSESP) and Emergency special program for 2019-nCoV of Guangdong province science and technology project (GDSTP-ESP) (2020B111105001).\n\n### Author Declarations\n\nAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.\n\nYes\n\nAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.\n\nYes\n\nI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).\n\nYes\n\nI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.\n\nYes\n\nI promise all data referred to in the manuscript are available.", "full_text_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.21.20026179v1.full", "public_url": "https://www.medrxiv.org/content/10.1101/2020.02.21.20026179v1", "abstract_html_url": "https://www.medrxiv.org/content/10.1101/2020.02.21.20026179v1.abstract", "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/02/25/2020.02.21.20026179.full.pdf", "rights": "\u00a9 2020, Posted by Cold Spring Harbor Laboratory. The copyright holder for this pre-print is the author. All rights reserved. The material may not be redistributed, re-used or adapted without the author's permission.", "publisher": "Cold Spring Harbor Laboratory Press", "pisa": "medrxiv;2020.02.21.20026179v1", "access_rights": "restricted", "authors": ["Liang Peng", "Jing Liu", "Wenxiong Xu", "Qiumin Luo", "Keji Deng", "Bingliang Lin", "Zhiliang Gao"]}